1. Home
  2. ARMP vs INTT Comparison

ARMP vs INTT Comparison

Compare ARMP & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARMP
  • INTT
  • Stock Information
  • Founded
  • ARMP N/A
  • INTT 1981
  • Country
  • ARMP United States
  • INTT United States
  • Employees
  • ARMP N/A
  • INTT N/A
  • Industry
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • INTT Semiconductors
  • Sector
  • ARMP Health Care
  • INTT Technology
  • Exchange
  • ARMP Nasdaq
  • INTT Nasdaq
  • Market Cap
  • ARMP 80.0M
  • INTT 91.4M
  • IPO Year
  • ARMP N/A
  • INTT 1997
  • Fundamental
  • Price
  • ARMP $2.06
  • INTT $8.87
  • Analyst Decision
  • ARMP Strong Buy
  • INTT Strong Buy
  • Analyst Count
  • ARMP 1
  • INTT 2
  • Target Price
  • ARMP $7.00
  • INTT $16.00
  • AVG Volume (30 Days)
  • ARMP 13.8K
  • INTT 43.5K
  • Earning Date
  • ARMP 11-13-2024
  • INTT 11-01-2024
  • Dividend Yield
  • ARMP N/A
  • INTT N/A
  • EPS Growth
  • ARMP N/A
  • INTT N/A
  • EPS
  • ARMP N/A
  • INTT 0.22
  • Revenue
  • ARMP $5,467,000.00
  • INTT $121,971,000.00
  • Revenue This Year
  • ARMP $23.87
  • INTT $7.31
  • Revenue Next Year
  • ARMP N/A
  • INTT $5.77
  • P/E Ratio
  • ARMP N/A
  • INTT $39.83
  • Revenue Growth
  • ARMP 34.92
  • INTT N/A
  • 52 Week Low
  • ARMP $1.80
  • INTT $6.28
  • 52 Week High
  • ARMP $4.48
  • INTT $14.35
  • Technical
  • Relative Strength Index (RSI)
  • ARMP 49.88
  • INTT 56.68
  • Support Level
  • ARMP $1.97
  • INTT $8.06
  • Resistance Level
  • ARMP $2.28
  • INTT $9.06
  • Average True Range (ATR)
  • ARMP 0.14
  • INTT 0.45
  • MACD
  • ARMP 0.01
  • INTT -0.02
  • Stochastic Oscillator
  • ARMP 54.17
  • INTT 47.37

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). They operate their business worldwide and sells its products both domestically and internationally.

Share on Social Networks: